Hair loss breakthrough? supplement shows promise in new study
NCT ID NCT07111312
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This 6-month study tested a daily drinkable supplement containing vitamins, minerals, and plant extracts in 106 women aged 18-40 with telogen effluvium (a common temporary hair loss). Half took the supplement, half took a placebo. Researchers measured hair density and growth cycle changes using scalp imaging. The goal was to see if the supplement could safely improve hair health.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
a drinkable supplement with vitamins, minerals, and plant extracts
What this could lead to
If it works, this could offer a natural option to help women with temporary hair loss regrow thicker hair.
What could go wrong
This is a small, completed study with 106 women. The supplement is not a drug, so effects may be modest. Results may not apply to all types of hair loss.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TELOGEN EFFLUVIUM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clínica AB Derma
Madrid, Spain
-
Zurko-CTC
Barcelona, Spain